Today's Low
₹ 640.95
Today's High
₹ 684.90
52 Weeks Low
₹ 554.05
52 Weeks High
₹ 850.50
Lower
₹ 538.50
Upper
₹ 807.70
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 100.5 | 82.8 | 78.3 | 63.4 | 60.7 | 74.0 | 50.1 | 91.9 | 25.5 | 25.9 |
Total Non-Current Assets | 40.0 | 41.1 | 42.0 | 60.8 | 63.5 | 82.7 | 68.3 | 18.7 | 22.7 | 15.6 |
Total Assets | 140.4 | 123.9 | 120.3 | 124.2 | 124.2 | 156.7 | 118.3 | 110.7 | 48.2 | 41.4 |
Total Current Liabilities | 28.0 | 25.9 | 27.3 | 38.0 | 36.7 | 47.3 | 17.6 | 13.9 | 9.6 | 8.2 |
Total Non-Current Liabilities | 3.7 | 3.1 | 3.8 | 3.9 | 10.3 | 8.0 | 4.2 | 3.5 | 12.5 | 9.8 |
Shareholder's Funds | 108.7 | 95.0 | 89.2 | 82.3 | 77.3 | 101.4 | 96.6 | 93.3 | 26.1 | 23.4 |
Total Liabilities | 140.4 | 123.9 | 120.3 | 124.2 | 124.2 | 156.7 | 118.3 | 110.7 | 48.2 | 41.4 |
The Industry Debt to Equity Ratio stands at 0.39, vs the Debt to Equity Ratio of 0.18, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.61, vs the Quick Ratio of 1.40, which results in a Negative aspect.
The Industry Current Ratio stands at 2.29, vs the Current Ratio of 1.67, which results in a Negative aspect.
The Industry Price to BV stands at 5.84, vs the Price to BV of 0.00, which results in a Negative aspect.
Particulars | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
---|---|---|---|---|---|---|---|---|---|---|
Total Income | 186.7 | 166.6 | 141.7 | 137.7 | 143.2 | 105.4 | 89.8 | 90.7 | 74.6 | 72.4 |
Total Expenditure | 156.0 | 143.0 | 120.8 | 120.2 | 124.9 | 92.2 | 77.4 | 77.8 | 63.2 | 56.8 |
Operating Profit(Excl OI) | 36.5 | 28.1 | 24.8 | 21.7 | 22.8 | 18.0 | 18.4 | 19.8 | 11.8 | 16.6 |
Add: Other Income | 5.7 | 4.5 | 3.9 | 4.3 | 4.6 | 4.8 | 6.0 | 6.9 | 0.4 | 1.0 |
Operating Profit | 36.5 | 28.1 | 24.8 | 21.7 | 22.8 | 18.0 | 18.4 | 19.8 | 11.8 | 16.6 |
Less: Interest | 0.4 | 0.7 | 1.8 | 2.5 | 3.1 | 0.6 | 0.3 | 0.4 | 1.0 | 0.8 |
PBDT | 36.0 | 27.4 | 23.0 | 19.2 | 19.7 | 17.4 | 18.1 | 19.4 | 10.8 | 15.8 |
Less: Depreciation Amortization | 3.4 | 3.2 | 3.6 | 3.7 | 3.6 | 1.8 | 1.3 | 1.6 | 2.1 | 1.5 |
PBT & Exceptional Items | 32.7 | 24.2 | 19.4 | 15.5 | 16.1 | 15.6 | 16.8 | 17.9 | 8.7 | 14.3 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.2 | 1.8 | 81.1 | 0.0 | -3.4 |
Profit Before Tax | 32.7 | 24.2 | 19.4 | 15.5 | 15.8 | 15.4 | 18.6 | 99.0 | 8.7 | 10.9 |
Less: Taxation | 12.1 | 9.3 | 6.9 | 5.4 | 6.2 | 5.2 | 7.1 | 6.6 | 3.7 | 5.0 |
Profit After Tax | 20.6 | 14.9 | 12.4 | 10.1 | 9.6 | 10.2 | 11.5 | 92.4 | 5.0 | 5.9 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.61, vs the Dividend Yield of 0.72, which results in a Positive aspect.
The Industry PAT Margin stands at 14.60, vs the PAT Margin of 6.97, which results in a Negative aspect.
The Industry PAT Growth stands at 21.44, vs the PAT Growth of 5.00, which results in a Negative aspect.
The Industry PE Ratio stands at 42.12, vs the PE Ratio of 87.23, which results in a Positive aspect.
Particulars | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 32.7 | 24.1 | 19.4 | 15.5 | 16.1 | 15.6 | 18.7 | 17.9 | 8.7 | 14.3 |
Tax Paid | -11.5 | -9.4 | -7.4 | -5.5 | -5.1 | -4.5 | -8.3 | -6.2 | -1.9 | -7.1 |
Adjustment | -1.3 | 0.3 | 3.5 | 3.1 | 2.7 | -1.4 | -1.8 | -4.7 | 2.8 | 1.5 |
Changes In Working Capital | 32.7 | 24.1 | 19.4 | 15.5 | 16.1 | 15.6 | 18.7 | 17.9 | 8.7 | 14.3 |
Cash Flow after changes in Working Capital | 32.2 | 27.7 | 24.8 | 14.1 | 8.7 | 10.2 | 19.8 | 12.0 | 7.0 | 18.1 |
Cash Flow from Operating Activities | 20.7 | 18.3 | 17.4 | 8.6 | 3.6 | 5.7 | 11.5 | 5.8 | 5.0 | 11.0 |
Cash Flow from Investing Activities | 4.2 | -4.9 | 16.5 | 7.7 | 14.5 | -29.4 | -47.0 | 89.0 | -8.3 | -4.1 |
Cash Flow from Financing Activities | -13.1 | -11.9 | -13.9 | -14.3 | -27.3 | 19.8 | -8.0 | -30.0 | -1.9 | -1.0 |
Net Cash Inflow / Outflow | 11.8 | 1.5 | 20.0 | 2.1 | -9.2 | -3.9 | -43.5 | 64.8 | -5.1 | 5.9 |
Opening Cash & Cash Equivalents | 30.7 | 29.2 | 9.1 | 7.1 | 24.4 | 28.4 | 67.6 | 2.8 | 7.9 | 2.0 |
Closing Cash & Cash Equivalent | 42.4 | 30.7 | 29.2 | 9.1 | 15.2 | 24.4 | 24.1 | 67.6 | 2.8 | 7.9 |
The Industry PFCF Ratio stands at 66.06, vs the PFCF Ratio of 10.43, which results in a Negative aspect.
The Industry PCF RATIO stands at 11.81, vs the PCF RATIO of 9.84, which results in a Negative aspect.
Particulars | |
---|---|
Net Sales | - |
Total Income | - |
Total Expenditure | - |
PBIDT (Excl OI) | - |
Other Income | - |
Operating Profit | - |
Interest | - |
Exceptional Items | - |
PBDT | - |
Depreciation | - |
Profit Before Tax | - |
Tax | - |
Provisions and contingencies | - |
Profit After Tax | - |
Net Profit | - |
ADDITIONAL INFOS: | |
Equity Capital | - |
Reserves | - |
EPS | - |
Operating Profit Margin | - |
Net Profit Margin | - |
The Industry Mcap Growth stands at 37.06, vs the Mcap Growth of -24.32, which results in a Negative aspect.
The Industry Net Sales Growth stands at 22.24, vs the Net Sales Growth of -3.84, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 665.50 | 679.96 | 645.71 |
R3 | 659.22 | 658.68 | 641.95 |
R2 | 652.93 | 652.66 | 640.70 |
R1 | 645.57 | 645.03 | 639.45 |
Pivot | 639.28 | 639.01 | 639.28 |
S1 | 631.92 | 631.38 | 636.95 |
S2 | 625.63 | 625.36 | 635.70 |
S3 | 618.27 | 617.73 | 634.45 |
S4 | 610.90 | 598.06 | 630.69 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
85.71
Bearish
RSI
60.71
Neutral
ROC
7.10
Bullish
UltimateOscillator
49.85
Neutral
Williams Indicator
-28.96
Neutral
CCI Indicator
82.18
Neutral
MACD
-2,448.30
Bearish
Stochastic Indicator
47.37
Neutral
ATR
21.72
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
20-02-2024 | 1.00 | 100 | Interim |
23-11-2023 | 1.00 | 100 | Interim |
14-09-2023 | 2.60 | 260 | Final |
24-02-2023 | 1.00 | 100 | Interim |
14-11-2022 | 1.00 | 100 | Interim |
14-09-2022 | 2.60 | 260 | Final |
18-02-2022 | 1.00 | 100 | Interim |
16-11-2021 | 1.00 | 100 | Interim |
15-09-2021 | 2.60 | 260 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
09-02-2024 | Quarterly Results & Interim Dividend |
10-11-2023 | Quarterly Results & Interim Dividend |
02-08-2023 | Quarterly Results |
30-06-2023 | Buy Back of Shares Inter alia, (a) To consider the proposal to appoint a director to fill the casual vacancy caused by the death of Dr. P.S.N. Murthi, Non-Executive Non-Independent Director; and (b) To consider a proposal for buyback offully paid-up equity shares of the Company of face value of< 1/- each as well as matters related/incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws. |
30-05-2023 | Audited Results (Revised) & Final Dividend |
27-05-2023 | Final Dividend & Audited Results |
14-02-2023 | Interim Dividend & Quarterly Results |
04-11-2022 | Quarterly Results & Interim Dividend |
12-08-2022 | Quarterly Results |
24-05-2022 | Final Dividend & Audited Results |
11-02-2022 | Quarterly Results & Interim Dividend |
09-11-2021 | Interim Dividend & Quarterly Results |
14-08-2021 | Quarterly Results |
29-06-2021 | Inter alia, to consider and approve Appointment of Additional Director (Non Executive Independent Catogery) |
27-05-2021 | Final Dividend & Audited Results |